Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 57 (representing 29 labs)

Tests names and labsConditionsGenes and analytesMethods

MELAS syndrome

Centogene AG - the Rare Disease Company
Germany
11
  • C Sequence analysis of the entire coding region

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, MT-CO2 related

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Otogenetics Hearing Loss and Deafness Multi-Gene NGS Panel

Otogenetics
United States
124129
  • E Sequence analysis of select exons

MELAS syndrome

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MELAS syndrome

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cardiomyopathy, idiopathic dilated, mitochondrial

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MELAS, MT-ND5-Related

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
10
  • T Targeted variant analysis

MELAS, MT-TL1-Related

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
10
  • T Targeted variant analysis

Mitochondrial Genome Sequence

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2238
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MT-ND5. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

MT-TL1. Detection of the mutations m.3243A>G, m.3271T>C and m.3252A>G by sequencing

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

MT-ND5. Detection of the mutations m.12770A>G, m.13045A>C, m.13084A>T, m.13513G>A and m.13514A>G by sequencing

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

MTND5. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

MTTL1. Detection of the mutations m.3243A>G, m.3271T>C and m.3252A>G by sequencing

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

MTND5. Detection of the mutations m.12770A>G, m.13045A>C, m.13084A>T, m.13513G>A and m.13514A>G by sequencing

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

Coenzyme Q10, Quantitative, Plasma

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
31
  • A Analyte

Coenzyme Q10, Quantitative, Leukocytes

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
31
  • A Analyte

Juvenile myopathy, encephalopathy, lactic acidosis AND stroke

Molecular Genetics and Cytogenetics, Clinical Laboratory Service Faculty of Medicine, Pontificia Universidad Católica de Chile
Chile
12
  • T Targeted variant analysis

PCR MERRF, MELAS

Molecular Pathology Laboratory Ohio State University
United States
11
  • T Targeted variant analysis

MELAS SYNDROME

Laboratorio de Genetica Clinica SL
Spain
12
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 57

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center